Skip to main content
Top
Published in: Sleep and Breathing 4/2015

01-12-2015 | Original Article

Effect of CPAP on arterial stiffness in severely obese patients with obstructive sleep apnoea

Authors: Ian W. Seetho, Rebecca Asher, Robert J. Parker, Sonya Craig, Nick Duffy, Kevin J. Hardy, John P. H. Wilding

Published in: Sleep and Breathing | Issue 4/2015

Login to get access

Abstract

Background

Obstructive sleep apnoea (OSA) may independently increase cardiovascular risk in obesity. Although there is evidence that arterial stiffness is altered in OSA, knowledge of these effects with continuous positive airway pressure (CPAP) in severe obesity (body mass index (BMI) ≥ 35 kg/m2) is limited. This study aimed to explore how arterial stiffness, as measured by the augmentation index (Aix), changed in severely obese patients with OSA who were treated with CPAP and in patients without OSA.

Methods

Forty-two patients with severe obesity—22 with OSA, 20 without OSA—were recruited at baseline and followed-up after a median of 13.5 months. Pulse wave analysis (PWA) was performed using applanation tonometry at the radial artery to measure augmentation index (Aix), augmentation pressure (AP) and subendocardial viability ratio (SEVR). Cardiovascular parameters and body composition were also measured.

Results

There were significant improvements in Aix, AP (both P < 0.001) and SEVR (P = 0.021) in OSA patients on CPAP compared with subjects without OSA. Epworth scores (P < 0.001), systolic (P < 0.001) and mean arterial pressures (P = 0.002) improved with CPAP. Regression showed that CPAP was significantly associated with change in arterial stiffness from baseline. However, patients with OSA on CPAP continued to have increased arterial stiffness (Aix) (P < 0.001), AP (P = 0.028) and reduced SEVR (P = 0.002) relative to non-OSA patients.

Conclusion

Although sleepiness and blood pressure improve with CPAP in severe obesity, CPAP alone is not sufficient to modify PWA measures to levels comparable with non-OSA patients. This supports a need for a multifaceted approach when managing cardiovascular risk in patients with severe obesity and obstructive sleep apnoea receiving CPAP therapy.
Literature
1.
go back to reference Peppard PE, Young T, Barnet JH, Palta M, Hagen E, Hla KM (2013) Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 177:1006–1014PubMedCentralCrossRefPubMed Peppard PE, Young T, Barnet JH, Palta M, Hagen E, Hla KM (2013) Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 177:1006–1014PubMedCentralCrossRefPubMed
2.
go back to reference Schwartz AR, Patil SP, Laffan AM, Polotsky V, Schneider H, Smith PL (2008) Obesity and obstructive sleep apnea: pathogenic mechanisms and therapeutic approaches. Proc Am Thorac Soc 5:185–192PubMedCentralCrossRefPubMed Schwartz AR, Patil SP, Laffan AM, Polotsky V, Schneider H, Smith PL (2008) Obesity and obstructive sleep apnea: pathogenic mechanisms and therapeutic approaches. Proc Am Thorac Soc 5:185–192PubMedCentralCrossRefPubMed
4.
go back to reference Montesi SB, Edwards BA, Malhotra A, Bakker JP (2012) The effect of continuous positive airway pressure treatment on blood pressure: a systematic review and meta-analysis of randomized controlled trials. J Clin Sleep Med 8:587–596PubMedCentralPubMed Montesi SB, Edwards BA, Malhotra A, Bakker JP (2012) The effect of continuous positive airway pressure treatment on blood pressure: a systematic review and meta-analysis of randomized controlled trials. J Clin Sleep Med 8:587–596PubMedCentralPubMed
5.
go back to reference Phillips CL, Butlin M, Wong KK, Avolio AP (2013) Is obstructive sleep apnoea causally related to arterial stiffness? A critical review of the experimental evidence. Sleep Med Rev 17:7–18CrossRefPubMed Phillips CL, Butlin M, Wong KK, Avolio AP (2013) Is obstructive sleep apnoea causally related to arterial stiffness? A critical review of the experimental evidence. Sleep Med Rev 17:7–18CrossRefPubMed
7.
go back to reference Doonan RJ, Scheffler P, Lalli M, Kimoff RJ, Petridou ET, Daskalopoulos ME, Daskalopoulou SS (2011) Increased arterial stiffness in obstructive sleep apnea: a systematic review. Hypertens Res 34:23–32CrossRefPubMed Doonan RJ, Scheffler P, Lalli M, Kimoff RJ, Petridou ET, Daskalopoulos ME, Daskalopoulou SS (2011) Increased arterial stiffness in obstructive sleep apnea: a systematic review. Hypertens Res 34:23–32CrossRefPubMed
8.
go back to reference Vlachantoni I-T, Dikaiakou E, Antonopoulos CN, Stefanadis C, Daskalopoulou SS, Petridou ET (2013) Effects of continuous positive airway pressure (CPAP) treatment for obstructive sleep apnea in arterial stiffness: a meta-analysis. Sleep Med Rev 17:19–28CrossRefPubMed Vlachantoni I-T, Dikaiakou E, Antonopoulos CN, Stefanadis C, Daskalopoulou SS, Petridou ET (2013) Effects of continuous positive airway pressure (CPAP) treatment for obstructive sleep apnea in arterial stiffness: a meta-analysis. Sleep Med Rev 17:19–28CrossRefPubMed
9.
go back to reference Bakker JP, Campbell AJ, Neill AM (2011) Pulse wave analysis in a pilot randomised controlled trial of auto-adjusting and continuous positive airway pressure for obstructive sleep apnoea. Sleep Breath 15:325–332CrossRefPubMed Bakker JP, Campbell AJ, Neill AM (2011) Pulse wave analysis in a pilot randomised controlled trial of auto-adjusting and continuous positive airway pressure for obstructive sleep apnoea. Sleep Breath 15:325–332CrossRefPubMed
10.
go back to reference Seetho IW, Parker RJ, Craig S, Duffy N, Hardy KJ, Wilding JP (2014) Obstructive sleep apnea is associated with increased arterial stiffness in severe obesity. J Sleep Res 23:700–708. doi:10.1111/jsr.12156 Seetho IW, Parker RJ, Craig S, Duffy N, Hardy KJ, Wilding JP (2014) Obstructive sleep apnea is associated with increased arterial stiffness in severe obesity. J Sleep Res 23:700–708. doi:10.​1111/​jsr.​12156
11.
go back to reference Chobanian AV, Bakris GL, Black HR et al (2003) Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42:1206–1252CrossRefPubMed Chobanian AV, Bakris GL, Black HR et al (2003) Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42:1206–1252CrossRefPubMed
12.
go back to reference Kelly R, Hayward C, Avolio A, O'Rourke M (1989) Non-invasive determination of age-related changes in the human arterial pulse. Circulation 80:1652–1659CrossRefPubMed Kelly R, Hayward C, Avolio A, O'Rourke M (1989) Non-invasive determination of age-related changes in the human arterial pulse. Circulation 80:1652–1659CrossRefPubMed
13.
go back to reference Pauca AL, O'Rourke MF, Kon ND (2001) Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension 38:932–937CrossRefPubMed Pauca AL, O'Rourke MF, Kon ND (2001) Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension 38:932–937CrossRefPubMed
14.
go back to reference Siebenhofer A, Kemp CRW, Sutton AJ, Williams B (1999) The reproducibility of central aortic blood pressure measurements in healthy subjects using applanation tonometry and sphygmocardiography. J Hum Hypertens 13:625–629CrossRefPubMed Siebenhofer A, Kemp CRW, Sutton AJ, Williams B (1999) The reproducibility of central aortic blood pressure measurements in healthy subjects using applanation tonometry and sphygmocardiography. J Hum Hypertens 13:625–629CrossRefPubMed
15.
go back to reference Noda A, Nakata S, Fukatsu H et al (2008) Aortic pressure augmentation as a marker of cardiovascular risk in obstructive sleep apnea syndrome. Hypertens Res 31:1109–1114CrossRefPubMed Noda A, Nakata S, Fukatsu H et al (2008) Aortic pressure augmentation as a marker of cardiovascular risk in obstructive sleep apnea syndrome. Hypertens Res 31:1109–1114CrossRefPubMed
16.
go back to reference Ferro G, Duilio C, Spinelli L, Liucci GA, Mazza F, Indolfi C (1995) Relation between diastolic perfusion time and coronary artery stenosis during stress-induced myocardial ischemia. Circulation 92:342–347CrossRefPubMed Ferro G, Duilio C, Spinelli L, Liucci GA, Mazza F, Indolfi C (1995) Relation between diastolic perfusion time and coronary artery stenosis during stress-induced myocardial ischemia. Circulation 92:342–347CrossRefPubMed
17.
go back to reference Flemons WW, Buysse D, Redline S et al (1999) Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 22:667–689 Flemons WW, Buysse D, Redline S et al (1999) Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 22:667–689
18.
go back to reference Engleman HM, Wild MR (2003) Improving CPAP use by patients with the sleep apnoea/hypopnoea syndrome. Sleep Med Rev 7:81–99CrossRefPubMed Engleman HM, Wild MR (2003) Improving CPAP use by patients with the sleep apnoea/hypopnoea syndrome. Sleep Med Rev 7:81–99CrossRefPubMed
19.
go back to reference Cleeman JI, Grundy SM, Becker D et al (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285:2486–2497CrossRef Cleeman JI, Grundy SM, Becker D et al (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285:2486–2497CrossRef
20.
go back to reference Chirinos JA, Zambrano JP, Chakko S, Veerani A, Schob A, Willens HJ, Perez G, Mendez AJ (2005) Aortic pressure augmentation predicts adverse cardiovascular events in patients with established coronary artery disease. Hypertension 45:980–985CrossRefPubMed Chirinos JA, Zambrano JP, Chakko S, Veerani A, Schob A, Willens HJ, Perez G, Mendez AJ (2005) Aortic pressure augmentation predicts adverse cardiovascular events in patients with established coronary artery disease. Hypertension 45:980–985CrossRefPubMed
21.
go back to reference Chemla D, Nitenberg A, Teboul J-L, Richard C, Monnet X, Le Clesiau H, Valensi P, Brahimi M (2008) Subendocardial viability ratio estimated by arterial tonometry: a critical evaluation in elderly hypertensive patients with increased aortic stiffness. Clin Exp Pharmacol Physiol 35:909–915CrossRefPubMed Chemla D, Nitenberg A, Teboul J-L, Richard C, Monnet X, Le Clesiau H, Valensi P, Brahimi M (2008) Subendocardial viability ratio estimated by arterial tonometry: a critical evaluation in elderly hypertensive patients with increased aortic stiffness. Clin Exp Pharmacol Physiol 35:909–915CrossRefPubMed
22.
go back to reference Tsiachris D, Tsioufis C, Syrseloudis D, Roussos D, Tatsis I, Dimitriadis K, Toutouzas K, Tsiamis E, Stefanadis C (2012) Subendocardial viability ratio as an index of impaired coronary flow reserve in hypertensives without significant coronary artery stenoses. J Hum Hypertens 26:64–70CrossRefPubMed Tsiachris D, Tsioufis C, Syrseloudis D, Roussos D, Tatsis I, Dimitriadis K, Toutouzas K, Tsiamis E, Stefanadis C (2012) Subendocardial viability ratio as an index of impaired coronary flow reserve in hypertensives without significant coronary artery stenoses. J Hum Hypertens 26:64–70CrossRefPubMed
23.
go back to reference Butt M, Khair OA, Dwivedi G, Shantsila A, Shantsila E, Lip GYH (2011) Myocardial perfusion by myocardial contrast echocardiography and endothelial dysfunction in obstructive sleep apnea. Hypertension 58:417–424CrossRefPubMed Butt M, Khair OA, Dwivedi G, Shantsila A, Shantsila E, Lip GYH (2011) Myocardial perfusion by myocardial contrast echocardiography and endothelial dysfunction in obstructive sleep apnea. Hypertension 58:417–424CrossRefPubMed
24.
go back to reference Barbé F, Durán-Cantolla J, Sánchez-de-la-Torre M et al (2012) Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea a randomized controlled trial. JAMA 307:2161–2168CrossRefPubMed Barbé F, Durán-Cantolla J, Sánchez-de-la-Torre M et al (2012) Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea a randomized controlled trial. JAMA 307:2161–2168CrossRefPubMed
25.
go back to reference Payne RA, Wilkinson IB, Webb DJ (2010) Arterial stiffness and hypertension emerging concepts. Hypertension 55:9–14CrossRefPubMed Payne RA, Wilkinson IB, Webb DJ (2010) Arterial stiffness and hypertension emerging concepts. Hypertension 55:9–14CrossRefPubMed
26.
go back to reference Coughlin SR, Mawdsley L, Mugarza JA, Calverley PMA, Wilding JPH (2004) Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 25:735–741CrossRefPubMed Coughlin SR, Mawdsley L, Mugarza JA, Calverley PMA, Wilding JPH (2004) Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 25:735–741CrossRefPubMed
27.
go back to reference Coughlin SR, Mawdsley L, Mugarza JA, Wilding JPH, Calverley PMA (2007) Cardiovascular and metabolic effects of CPAP in obese males with OSA. Eur Respir J 29:720–727CrossRefPubMed Coughlin SR, Mawdsley L, Mugarza JA, Wilding JPH, Calverley PMA (2007) Cardiovascular and metabolic effects of CPAP in obese males with OSA. Eur Respir J 29:720–727CrossRefPubMed
28.
go back to reference Steiropoulos P, Tsara V, Nena E, Fitili C, Kataropoulou M, Froudarakis M, Christaki P (2007) Effect of continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome. Chest 132:843–851CrossRefPubMed Steiropoulos P, Tsara V, Nena E, Fitili C, Kataropoulou M, Froudarakis M, Christaki P (2007) Effect of continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome. Chest 132:843–851CrossRefPubMed
29.
go back to reference Chirinos JA, Gurubhagavatula I, Pack A et al (2013) Effect of continuous-positive airway pressure, weight loss or both on large artery stiffness in subjects with obstructive sleep apnea. J Am Coll Cardiol 61:E1448CrossRef Chirinos JA, Gurubhagavatula I, Pack A et al (2013) Effect of continuous-positive airway pressure, weight loss or both on large artery stiffness in subjects with obstructive sleep apnea. J Am Coll Cardiol 61:E1448CrossRef
30.
go back to reference Laurent S, Cockcroft J, Van Bortel L et al (2006) Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 27:2588–2605CrossRefPubMed Laurent S, Cockcroft J, Van Bortel L et al (2006) Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 27:2588–2605CrossRefPubMed
31.
go back to reference Wilkinson IB, Fuchs SA, Jansen IM, Spratt JC, Murray GD, Cockcroft JR, Webb DJ (1998) Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens 16:2079–2084CrossRefPubMed Wilkinson IB, Fuchs SA, Jansen IM, Spratt JC, Murray GD, Cockcroft JR, Webb DJ (1998) Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens 16:2079–2084CrossRefPubMed
Metadata
Title
Effect of CPAP on arterial stiffness in severely obese patients with obstructive sleep apnoea
Authors
Ian W. Seetho
Rebecca Asher
Robert J. Parker
Sonya Craig
Nick Duffy
Kevin J. Hardy
John P. H. Wilding
Publication date
01-12-2015
Publisher
Springer Berlin Heidelberg
Published in
Sleep and Breathing / Issue 4/2015
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-015-1131-0

Other articles of this Issue 4/2015

Sleep and Breathing 4/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine